StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.08 (-4.94%)

Close on Nov 18, 2026Market cap $14.57MP/E –Yield –

XTL Biopharmaceuticals shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

XTL Biopharmaceuticals's shares outstanding was 545M at Jun 30, 2022. For fiscal 2025 it was 896M, up 33.2% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 896M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025896M+33.2%
FY2024Dec 31, 2024673M+23.5%
FY2023Dec 31, 2023545M-0.0%
FY2022Dec 31, 2022545M-11.5%
FY2021Dec 31, 2021616M+19.7%
FY2020Dec 31, 2020514M0.0%
FY2019Dec 31, 2019514M0.0%
FY2018Dec 31, 2018514M+9.4%
FY2017Dec 31, 2017470M+71.6%
FY2016Dec 31, 2016274M+3.9%
FY2015Dec 31, 2015264M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2022Jun 30, 2022545M–
Q2 FY2021Jun 30, 2021528M–
Q2 FY2020Jun 30, 2020514M–

More XTL Biopharmaceuticals figures

See a number that looks wrong?